<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02206126</url>
  </required_header>
  <id_info>
    <org_study_id>CLINEX05</org_study_id>
    <nct_id>NCT02206126</nct_id>
  </id_info>
  <brief_title>Weight Loss and Obstructive Sleep Apnea</brief_title>
  <official_title>Effects of Energy Restriction on Sleep Apnea, Sympathetic Activity, Oxidative Stress, Inflammatory Biomarkers, Endothelial Function, Body Adiposity, Metabolic Profile and Blood Pressure in Obese Patients With Obstructive Sleep Apnea</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rio de Janeiro State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rio de Janeiro State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effects of moderate energy restriction on the&#xD;
      body adiposity, severity of OSA, blood pressure, sympathetic activity, oxidative stress,&#xD;
      inflammatory biomarkers, metabolic profile and endothelial function in obese patients with&#xD;
      OSA.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Introduction: Nutritional intervention for weight loss is one of the treatment options for&#xD;
      obstructive sleep apnea (OSA) in patients with excess body adiposity. However, the effects of&#xD;
      moderate energy restriction, recommended by current guidelines for the treatment of obesity,&#xD;
      on OSA are not yet known. Objective: To evaluate the effects of moderate energy restriction&#xD;
      on the body adiposity; severity of OSA; blood pressure; sympathetic activity; oxidative&#xD;
      stress; inflammatory biomarkers; metabolic profile and endothelial function in obese patients&#xD;
      with OSA. Methods: A 16-week randomized clinical trial, involving 21 subjects with obesity&#xD;
      (grade I or II), aged 20-55 years and presenting an apnea/hipopnea index (AHI) &gt; 5 events/h.&#xD;
      Participants were randomized into 2 groups: 11 in the energy restriction group (ERG) and 10&#xD;
      in the control group (CG). The ERG was instructed to follow an energy-restricted diet (-800&#xD;
      kcal/day) and the CG was advised not to change their food intake. At the beginning and at the&#xD;
      end of the study, participants underwent evaluation of: OSA with the equipment Watch- PAT200®&#xD;
      including the determination of the following parameters of OSA severity: AHI, minimum O2&#xD;
      saturation, number of O2 desaturations &gt;4%; body adiposity (weight, %body fat and&#xD;
      circumferences of waist, hip and neck); blood pressure (BP); sympathetic nervous system&#xD;
      activity (plasma levels of catecholamines); inflammatory biomarkers (c-reactive protein and&#xD;
      adiponectin); oxidative stress (malondialdehyde); metabolism of glucose (glucose, insulin and&#xD;
      HOMA-IR) and lipids (total cholesterol and fractions and triglycerides); and endothelial&#xD;
      function (index of reactive hyperemia evaluated by Endo - PAT 2000® and cellular adhesion&#xD;
      molecules). The statistical analysis was performed with the software STATA v. 10. The level&#xD;
      of statistical significance was p &lt; 0.05.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Actual">October 2013</completion_date>
  <primary_completion_date type="Actual">October 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Apnea/hipopnea index</measure>
    <time_frame>16 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>16 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sympathetic activity</measure>
    <time_frame>16 weeks</time_frame>
    <description>Plasma levels of catecholamines</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxidative stress</measure>
    <time_frame>16 weeks</time_frame>
    <description>Serum levels of malondialdehyde</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammatory biomarkers</measure>
    <time_frame>16 weeks</time_frame>
    <description>Circulating levels of high-sensitivity C reactive protein and adiponectin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Metabolic profile</measure>
    <time_frame>16 weeks</time_frame>
    <description>Fasting plasma glucose, insulin, total cholesterol, HDL-cholesterol, LDL-cholesterol and triglycerides</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endothelial function</measure>
    <time_frame>16 weeks</time_frame>
    <description>Circulating levels of cellular adhesion molecules (intercellular adhesion molecule 1 and P-selectin).&#xD;
Endothelial function was also evaluated by the PAT method, using Endo-PAT 2000®.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">21</enrollment>
  <condition>Obstructive Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>Energy restriction group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The energy restriction group was instructed to follow an energy-restricted diet (-800 kcal/day).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The control group was advised not to change their food intake.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Energy Restriction</intervention_name>
    <description>The energy restriction group was instructed to follow an energy-restricted diet (-800 kcal/day).</description>
    <arm_group_label>Energy restriction group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age between 20-55 years&#xD;
&#xD;
          -  body mass index (BMI) ≥ 30 kg/m2 and &lt; 40 kg/m2&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  smoking&#xD;
&#xD;
          -  Use of dietary supplements&#xD;
&#xD;
          -  Use of medications that could interfere in body weight, metabolic profile and blood&#xD;
             pressure&#xD;
&#xD;
          -  Use of permanent pacemaker; use of α-adrenergic blocking agents&#xD;
&#xD;
          -  Recent changes (within previous 6 months) in body weight (&gt; 3 kg), in dietary intake&#xD;
             and in intensity or frequency of physical exercise&#xD;
&#xD;
          -  Diagnosis of diabetes mellitus, hypertension, dyslipidemia (with drug treatment) and&#xD;
             kidney disease&#xD;
&#xD;
          -  Clinical history of thyroid dysfunction, angina pectoris, peripheral vascular disease,&#xD;
             peripheral neuropathy, heart failure, liver failure, chronic pulmonary disease,&#xD;
             gastroesophageal reflux disease, myocardial infarction and stroke; finger deformity&#xD;
             that prevents the proper use of the sensors that are necessary to evaluate OSA and&#xD;
             endothelial function; and previous bilateral cervical-thoracic sympathectomy&#xD;
&#xD;
          -  Pregnant or lactating women were not allowed into the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antonio Felipe Sanjuliani, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rio de Janeiro State University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Discipline of Clinical and Experimental Pathophysiology, CLINEX</name>
      <address>
        <city>Rio de Janeiro</city>
        <zip>20.551-030</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>July 2014</verification_date>
  <study_first_submitted>June 27, 2014</study_first_submitted>
  <study_first_submitted_qc>July 30, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 1, 2014</study_first_posted>
  <last_update_submitted>July 30, 2014</last_update_submitted>
  <last_update_submitted_qc>July 30, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 1, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rio de Janeiro State University</investigator_affiliation>
    <investigator_full_name>Antonio Felipe Sanjuliani</investigator_full_name>
    <investigator_title>Antonio Felipe Sanjuliani</investigator_title>
  </responsible_party>
  <keyword>Obstructive sleep apnea</keyword>
  <keyword>Weight loss</keyword>
  <keyword>Obesity</keyword>
  <keyword>Sympathetic activity</keyword>
  <keyword>Metabolic profile</keyword>
  <keyword>Endothelial function</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

